| 1 |
30953637 | Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics. | 2019 Jun |
1 |
| 2 |
27495788 | Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice. | 2016 Oct |
1 |
| 3 |
25663899 | Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells. | 2015 Mar |
2 |
| 4 |
26011058 | Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently. | 2015 Aug |
1 |
| 5 |
23843632 | Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib. | 2013 Sep |
1 |
| 6 |
24113148 | Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain. | 2013 Dec |
2 |
| 7 |
21351087 | Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. | 2012 Jan 1 |
8 |
| 8 |
22238213 | P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinib. | 2012 Apr |
2 |
| 9 |
22673043 | Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. | 2012 |
2 |
| 10 |
21309545 | Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier. | 2011 Apr 4 |
1 |